About the Institute

The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.

Fulfilling an essential need within healthcare, the Institute delivers objective, relevant insights and research that accelerate understanding and innovation critical to sound decision making and improved human outcomes. With access to IQVIA’s institutional knowledge, advanced analytics, technology and unparalleled data the Institute works in tandem with a broad set of healthcare stakeholders to drive a research agenda focused on Human Data Science, including government agencies, academic institutions, the life sciences industry and payers.

Featured Report

Global Oncology Trends 2018

Cancer treatments have been advancing at an accelerated pace in recent years, offering notable improvements in clinical benefit to patients. This report highlights advances in cancer therapeutics, including the use of these drugs and their global spending trends, the pipeline of therapeutic innovation and associated clinical trial activity, and the outlook through 2022. The report aims to provide an evidence base that can be used in discussion about the broader implications for cancer patients and their families, providers and their institutions, public and private payers at the local and national level, as well as multinational organizations.

Institute Leaders

Murray Aitken

Murray Aitken

Senior Vice President and
Executive Director

Michael Kleinrock

Michael Kleinrock

Director Research Development

Research Support

The IQVIA Institute leverages collaborative relationships in the public and private sectors to provide market clarity in advancing human science globally through fact based healthcare discussions.

LEARN MORE

EVENTS & WEBINARS
Find where Murray Aitken and Michael Kleinrock will be speaking next
MEDIA

See press releases and news coverage about the IQVIA Institute

Engage with Murray Aitken on Twitter